Featured Article

Inflammation and Oxidative Stress in Diabetic Kidney Disease. irresistible inspiration

Heather Aug 05, 2026

Inflammation and Oxidative Stress in Diabetic Kidney Disease

Inflammation and Oxidative Stress in Diabetic Kidney Disease
Inflammation and Oxidative Stress in Diabetic Kidney Disease

The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (DKD) remains one of the leading long-term complications of T2D. Several lines of evidence indicate that glucose-lowering agents prevent the onset and progression ...

Brasil Kidney effects of Glucagon Like Peptide 1 GLP1
Brasil Kidney effects of Glucagon Like Peptide 1 GLP1

The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (DKD) remains one of the leading long-term complications of T2D. Several lines of evidence indicate that glucose-lowering agents prevent the onset and progression of DKD in its early stages but are of limited efficacy in later stages of DKD. However, sodium-glucose cotransporter-2 inhibitors ...

Oxidative stress as a culprit in diabetic kidney disease

GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Call

Oxidative stress and inflammation may be considered reciprocal causes of DKD, in that each is a cause and an effect of DKD. Reactive oxygen species (ROS) can act as second messengers in various signaling pathways and as regulators of metabolism, activation, proliferation, differentiation, and apoptosis of immune cells.

Diabetic nephropathy (DN) remains a leading cause of end-stage renal disease , with inflammation and fibrosis serving as pivotal drivers of disease progression. Chronic hyperglycemia induces oxidative stress , activates immune pathways, and promotes extracellular matrix (ECM) accumulation, leading to irreversible kidney damage.

GLP 1 receptor agonists reduce kidney failure risk and cardiovascular
GLP 1 receptor agonists reduce kidney failure risk and cardiovascular

Role of inflammation in the progression of diabetic kidney disease

Zhong M, Zhu E, Li N, et al. Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: evidence from human transcriptomic data and mouse experiments.

A recent investigation of the ER-resident UDPase ENTPD5 demonstrates its dual role in mediating protein N-glycosylation and modulating endoplasmic reticulum stress in diabetic kidney disease .

Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists

Oxidative Stress

Tofogliflozin, a highly specific inhibitor of SGLT2, exerts anti-inflammatory and antifibrotic effects on experimental diabetic nephropathy partly by curbing the formation of AGEs and oxidative stress in the kidney [17].

Abstract Diabetic nephropathy (DN) often leads to end-stage renal disease . Oxidative stress demonstrates a crucial act in the onset and progression of DN, which triggers various pathological processes while promoting the activation of inflammation and forming a vicious oxidative stress - inflammation cycle that induces podocyte injury, extracellular matrix accumulation, glomerulosclerosis ...

SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation

Immune inflammation and metabolic interactions in the ...

Inflammation and oxidative stress are significant contributors to insulin resistance and diabetic nephropathy. Active inflammatory pathways promote the generation of reactive oxygen species (ROS), which worsen insulin resistance and cause renal tissue damage.

Glucagon Like Peptide 1 Receptor Agonists and Heart Failure
Glucagon Like Peptide 1 Receptor Agonists and Heart Failure
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Game Charger
GLP 1 Receptor Agonists and Diabetic Kidney Disease A Game Charger
GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1
GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1
Cardiovascular Effects of GLP 1 Receptor Agonists
Cardiovascular Effects of GLP 1 Receptor Agonists
Glucagon like peptide 1 GLP 1 receptor agonists in the management
Glucagon like peptide 1 GLP 1 receptor agonists in the management
GLP 1 receptor agonists effects on established and presumed drivers
GLP 1 receptor agonists effects on established and presumed drivers
Diabetes and Coronary Artery Disease PowerPoint Presentation
Diabetes and Coronary Artery Disease PowerPoint Presentation

In this Review, the authors discuss the mechanisms by which diabetes mellitus can lead to kidney damage and describe the clinical characteristics of diabetic kidney disease . The Review also covers ...